Jason K. Johnson - 01 Mar 2026 Form 4 Insider Report for COMMUNITY HEALTH SYSTEMS INC (CYH)

Role
EVP & CFO
Signature
Christopher G. Cobb, Attorney in Fact for Jason K. Johnson
Issuer symbol
CYH
Transactions as of
01 Mar 2026
Net transactions value
-$81,691
Form type
4
Filing time
03 Mar 2026, 16:45:37 UTC
Previous filing
03 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Johnson Jason K EVP & CFO 4000 MERIDIAN BOULEVARD, FRANKLIN Christopher G. Cobb, Attorney in Fact for Jason K. Johnson 03 Mar 2026 0001798438

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYH Common Stock Options Exercise $0 +30,000 +17% $0.000000 202,049 01 Mar 2026 Direct F1
transaction CYH Common Stock Award $0 +90,000 +45% $0.000000 292,049 01 Mar 2026 Direct F2
transaction CYH Common Stock Tax liability $81,691 -23,610 -8.1% $3.46 268,439 01 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYH Performance Based Restricted Options Exercise $0 -30,000 -100% $0.000000 0 01 Mar 2026 Common Stock 30,000 $0.000000 Direct F1
transaction CYH Performance Based Restricted Award $0 +180,000 $0.000000 180,000 01 Mar 2026 Common Stock 180,000 $0.000000 Direct F3
transaction CYH Stock Options (Right to Buy) Award $0 +90,000 $0.000000 90,000 01 Mar 2026 Common Stock 90,000 $3.46 Direct F4
holding CYH Performance Based Restricted 30,000 01 Mar 2026 Common Stock 30,000 $0.000000 Direct F5
holding CYH Performance Based Restricted 30,000 01 Mar 2026 Common Stock 30,000 $0.000000 Direct F6
holding CYH Stock Options (Right to Buy) 15,000 01 Mar 2026 Common Stock 15,000 $4.93 Direct
holding CYH Stock Options (Right to Buy) 18,000 01 Mar 2026 Common Stock 18,000 $8.81 Direct
holding CYH Stock Options (Right to Buy) 25,000 01 Mar 2026 Common Stock 25,000 $10.18 Direct
holding CYH Stock Options (Right to Buy) 30,000 01 Mar 2026 Common Stock 30,000 $6.15 Direct
holding CYH Stock Options (Right to Buy) 30,000 01 Mar 2026 Common Stock 30,000 $2.87 Direct F4
holding CYH Stock Options (Right to Buy) 30,000 01 Mar 2026 Common Stock 30,000 $3.01 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.
F2 The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
F3 The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 40% to a Cumulative Same-Store Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.
F4 Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
F5 The vesting of these performance-based restricted shares is subject to the Issuer's attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
F6 The vesting of these performance-based restricted shares is subject to the Issuer's attainment of certain performance objectives between 1/1/2025 and 12/31/2027 (the "2025-2027 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2025-2027 Performance Period.